While Rhya Pharms has received some initial equity funding, we are considering additional investors at this time in order to more rapidly respond to the market demand for our products. Slow, organic growth is often preferable in mature markets. However, as the incredible health benefits of new remedies are emerging, we feel an aggressive growth during 2015 to establish market share for our brands is a key to long-term success.

Rhya Pharms has solid marketing and growth plans to become a dominant manufacturer in the nutraceutical industry. Please contact us to learn more about your potential return on an investment in Rhya Pharms.

Investor Relations
Clint Crary
(530) 757-7492

Rhya Pharms does not sell or distribute any products that are in violation of the United States Controlled Substances Act (USA CDA).

FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSURE Statements on this website have not been evaluated by the FDA and are not intended to diagnose, treat, or cure any disease. Always check with your physician before starting a new dietary supplement program.